share_log

国投证券4月16日发布研报称,给予神州细胞(688520.SH)买入评级,目标价格为51.06元。评级理由主要包括:1)2023年公司毛利率小幅提升,期间费用率有所优化;2)重组八因子收入快速增长,出海布局持续推进。(每日经济新闻)

SDIC Securities released a research report on April 16 stating that it gave Shenzhou Cell (688520.SH) a purchase rating and the target price was 51.06 yuan. The main reasons for the rating include: 1) the company's gross margin increased slightly in 2023,

Zhitong Finance ·  Apr 17 07:36
SDIC Securities released a research report on April 16 stating that it gave Shenzhou Cell (688520.SH) a purchase rating and the target price was 51.06 yuan. The main reasons for the rating include: 1) the company's gross margin increased slightly in 2023, and the cost ratio was optimized during the period; 2) the eight factor restructuring revenue grew rapidly, and the overseas layout continued to advance. (Mainichi Keizai Shimbun)

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment